nodes	percent_of_prediction	percent_of_DWPC	metapath
Ondansetron—CYP1A2—Carmustine—malignant glioma	0.205	0.57	CbGbCtD
Ondansetron—CYP3A4—Temozolomide—malignant glioma	0.155	0.431	CbGbCtD
Ondansetron—HTR3A—fourth ventricle—malignant glioma	0.0442	0.195	CbGeAlD
Ondansetron—HTR1B—dura mater—malignant glioma	0.0431	0.191	CbGeAlD
Ondansetron—Injection site burning—Carmustine—malignant glioma	0.038	0.171	CcSEcCtD
Ondansetron—Wound—Carmustine—malignant glioma	0.0247	0.111	CcSEcCtD
Ondansetron—Tonic-clonic seizures—Carmustine—malignant glioma	0.0133	0.0597	CcSEcCtD
Ondansetron—OPRM1—telencephalic ventricle—malignant glioma	0.0117	0.0519	CbGeAlD
Ondansetron—HTR4—telencephalon—malignant glioma	0.0114	0.0503	CbGeAlD
Ondansetron—HTR1B—telencephalic ventricle—malignant glioma	0.0107	0.0475	CbGeAlD
Ondansetron—HTR1A—telencephalic ventricle—malignant glioma	0.00866	0.0383	CbGeAlD
Ondansetron—Grand mal convulsion—Carmustine—malignant glioma	0.00753	0.0338	CcSEcCtD
Ondansetron—HTR1B—blood vessel—malignant glioma	0.00531	0.0235	CbGeAlD
Ondansetron—HTR4—brain—malignant glioma	0.00513	0.0227	CbGeAlD
Ondansetron—SLC47A2—central nervous system—malignant glioma	0.0049	0.0217	CbGeAlD
Ondansetron—Injection site pain—Carmustine—malignant glioma	0.00439	0.0197	CcSEcCtD
Ondansetron—SLC47A2—brain—malignant glioma	0.00389	0.0172	CbGeAlD
Ondansetron—Injection site reaction—Carmustine—malignant glioma	0.00356	0.016	CcSEcCtD
Ondansetron—Musculoskeletal pain—Temozolomide—malignant glioma	0.0035	0.0157	CcSEcCtD
Ondansetron—HTR3A—brainstem—malignant glioma	0.00346	0.0153	CbGeAlD
Ondansetron—SLC47A1—brainstem—malignant glioma	0.0034	0.015	CbGeAlD
Ondansetron—OPRM1—brainstem—malignant glioma	0.00317	0.014	CbGeAlD
Ondansetron—HTR3A—telencephalon—malignant glioma	0.00307	0.0136	CbGeAlD
Ondansetron—Swelling—Carmustine—malignant glioma	0.00295	0.0132	CcSEcCtD
Ondansetron—HTR1B—brainstem—malignant glioma	0.0029	0.0128	CbGeAlD
Ondansetron—OPRM1—telencephalon—malignant glioma	0.00282	0.0125	CbGeAlD
Ondansetron—Hepatic failure—Temozolomide—malignant glioma	0.0028	0.0126	CcSEcCtD
Ondansetron—HTR1B—telencephalon—malignant glioma	0.00258	0.0114	CbGeAlD
Ondansetron—Liver function test abnormal—Carmustine—malignant glioma	0.0024	0.0108	CcSEcCtD
Ondansetron—SLC47A1—medulla oblongata—malignant glioma	0.00237	0.0105	CbGeAlD
Ondansetron—Hypokalaemia—Carmustine—malignant glioma	0.00237	0.0106	CcSEcCtD
Ondansetron—HTR1A—brainstem—malignant glioma	0.00234	0.0104	CbGeAlD
Ondansetron—Hypokalaemia—Temozolomide—malignant glioma	0.00229	0.0103	CcSEcCtD
Ondansetron—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.00226	0.0102	CcSEcCtD
Ondansetron—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.00226	0.0102	CcSEcCtD
Ondansetron—SLC47A1—spinal cord—malignant glioma	0.00211	0.00935	CbGeAlD
Ondansetron—HTR1A—telencephalon—malignant glioma	0.00208	0.0092	CbGeAlD
Ondansetron—Dysuria—Temozolomide—malignant glioma	0.00203	0.00912	CcSEcCtD
Ondansetron—OPRM1—midbrain—malignant glioma	0.00202	0.00895	CbGeAlD
Ondansetron—OPRM1—spinal cord—malignant glioma	0.00197	0.00873	CbGeAlD
Ondansetron—Urinary tract infection—Carmustine—malignant glioma	0.00195	0.00874	CcSEcCtD
Ondansetron—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.00192	0.00862	CcSEcCtD
Ondansetron—Urinary tract infection—Temozolomide—malignant glioma	0.00188	0.00845	CcSEcCtD
Ondansetron—KCNH2—telencephalon—malignant glioma	0.00185	0.00819	CbGeAlD
Ondansetron—HTR1B—midbrain—malignant glioma	0.00185	0.00819	CbGeAlD
Ondansetron—Hepatobiliary disease—Temozolomide—malignant glioma	0.00183	0.00822	CcSEcCtD
Ondansetron—Haemoglobin—Carmustine—malignant glioma	0.00181	0.00812	CcSEcCtD
Ondansetron—HTR1B—spinal cord—malignant glioma	0.00181	0.00799	CbGeAlD
Ondansetron—Haemorrhage—Carmustine—malignant glioma	0.0018	0.00808	CcSEcCtD
Ondansetron—Haemoglobin—Temozolomide—malignant glioma	0.00175	0.00784	CcSEcCtD
Ondansetron—HTR3A—central nervous system—malignant glioma	0.00175	0.00772	CbGeAlD
Ondansetron—Haemorrhage—Temozolomide—malignant glioma	0.00174	0.0078	CcSEcCtD
Ondansetron—Visual impairment—Carmustine—malignant glioma	0.00173	0.00778	CcSEcCtD
Ondansetron—SLC47A1—central nervous system—malignant glioma	0.00172	0.00759	CbGeAlD
Ondansetron—Eye disorder—Carmustine—malignant glioma	0.00168	0.00755	CcSEcCtD
Ondansetron—SLC47A1—cerebellum—malignant glioma	0.00168	0.00742	CbGeAlD
Ondansetron—Visual impairment—Temozolomide—malignant glioma	0.00168	0.00752	CcSEcCtD
Ondansetron—Flushing—Carmustine—malignant glioma	0.00167	0.00749	CcSEcCtD
Ondansetron—Erythema multiforme—Temozolomide—malignant glioma	0.00164	0.00738	CcSEcCtD
Ondansetron—Eye disorder—Temozolomide—malignant glioma	0.00163	0.00729	CcSEcCtD
Ondansetron—Cardiac disorder—Temozolomide—malignant glioma	0.00161	0.00724	CcSEcCtD
Ondansetron—Flushing—Temozolomide—malignant glioma	0.00161	0.00724	CcSEcCtD
Ondansetron—Arrhythmia—Carmustine—malignant glioma	0.00161	0.00721	CcSEcCtD
Ondansetron—OPRM1—central nervous system—malignant glioma	0.0016	0.00708	CbGeAlD
Ondansetron—Angiopathy—Temozolomide—malignant glioma	0.00158	0.00708	CcSEcCtD
Ondansetron—Immune system disorder—Temozolomide—malignant glioma	0.00157	0.00705	CcSEcCtD
Ondansetron—Mediastinal disorder—Temozolomide—malignant glioma	0.00157	0.00703	CcSEcCtD
Ondansetron—Erythema—Carmustine—malignant glioma	0.00157	0.00703	CcSEcCtD
Ondansetron—Chills—Temozolomide—malignant glioma	0.00156	0.007	CcSEcCtD
Ondansetron—Erythema—Temozolomide—malignant glioma	0.00151	0.00679	CcSEcCtD
Ondansetron—HTR1A—midbrain—malignant glioma	0.00149	0.00661	CbGeAlD
Ondansetron—Vision blurred—Carmustine—malignant glioma	0.00148	0.00663	CcSEcCtD
Ondansetron—Tremor—Carmustine—malignant glioma	0.00147	0.00659	CcSEcCtD
Ondansetron—HTR1B—central nervous system—malignant glioma	0.00146	0.00648	CbGeAlD
Ondansetron—HTR1A—spinal cord—malignant glioma	0.00146	0.00645	CbGeAlD
Ondansetron—KCNH2—medulla oblongata—malignant glioma	0.00145	0.00644	CbGeAlD
Ondansetron—Agitation—Carmustine—malignant glioma	0.00144	0.00646	CcSEcCtD
Ondansetron—Vision blurred—Temozolomide—malignant glioma	0.00143	0.0064	CcSEcCtD
Ondansetron—CYP2E1—telencephalon—malignant glioma	0.00143	0.00631	CbGeAlD
Ondansetron—Tremor—Temozolomide—malignant glioma	0.00142	0.00636	CcSEcCtD
Ondansetron—Ill-defined disorder—Temozolomide—malignant glioma	0.0014	0.0063	CcSEcCtD
Ondansetron—Agitation—Temozolomide—malignant glioma	0.00139	0.00624	CcSEcCtD
Ondansetron—HTR3A—brain—malignant glioma	0.00139	0.00613	CbGeAlD
Ondansetron—Angioedema—Temozolomide—malignant glioma	0.00138	0.00621	CcSEcCtD
Ondansetron—Malaise—Temozolomide—malignant glioma	0.00137	0.00613	CcSEcCtD
Ondansetron—SLC47A1—brain—malignant glioma	0.00136	0.00602	CbGeAlD
Ondansetron—Convulsion—Carmustine—malignant glioma	0.00136	0.00609	CcSEcCtD
Ondansetron—Palpitations—Temozolomide—malignant glioma	0.00134	0.006	CcSEcCtD
Ondansetron—Chest pain—Carmustine—malignant glioma	0.00133	0.00599	CcSEcCtD
Ondansetron—KCNH2—midbrain—malignant glioma	0.00133	0.00588	CbGeAlD
Ondansetron—Anxiety—Carmustine—malignant glioma	0.00133	0.00596	CcSEcCtD
Ondansetron—Cough—Temozolomide—malignant glioma	0.00132	0.00593	CcSEcCtD
Ondansetron—Convulsion—Temozolomide—malignant glioma	0.00131	0.00589	CcSEcCtD
Ondansetron—KCNH2—spinal cord—malignant glioma	0.0013	0.00574	CbGeAlD
Ondansetron—Anxiety—Temozolomide—malignant glioma	0.00128	0.00576	CcSEcCtD
Ondansetron—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00128	0.00574	CcSEcCtD
Ondansetron—Discomfort—Temozolomide—malignant glioma	0.00127	0.00571	CcSEcCtD
Ondansetron—CYP2D6—brainstem—malignant glioma	0.00127	0.00563	CbGeAlD
Ondansetron—OPRM1—brain—malignant glioma	0.00127	0.00562	CbGeAlD
Ondansetron—Dry mouth—Temozolomide—malignant glioma	0.00126	0.00566	CcSEcCtD
Ondansetron—Tachycardia—Carmustine—malignant glioma	0.00125	0.0056	CcSEcCtD
Ondansetron—Anaphylactic shock—Temozolomide—malignant glioma	0.00124	0.00554	CcSEcCtD
Ondansetron—Nervous system disorder—Temozolomide—malignant glioma	0.00121	0.00544	CcSEcCtD
Ondansetron—Skin disorder—Temozolomide—malignant glioma	0.0012	0.00539	CcSEcCtD
Ondansetron—Hypotension—Carmustine—malignant glioma	0.00119	0.00536	CcSEcCtD
Ondansetron—HTR1A—central nervous system—malignant glioma	0.00118	0.00523	CbGeAlD
Ondansetron—HTR1B—brain—malignant glioma	0.00116	0.00514	CbGeAlD
Ondansetron—HTR1A—cerebellum—malignant glioma	0.00116	0.00511	CbGeAlD
Ondansetron—Paraesthesia—Carmustine—malignant glioma	0.00115	0.00515	CcSEcCtD
Ondansetron—Dyspnoea—Carmustine—malignant glioma	0.00114	0.00512	CcSEcCtD
Ondansetron—Somnolence—Carmustine—malignant glioma	0.00114	0.0051	CcSEcCtD
Ondansetron—CYP2D6—telencephalon—malignant glioma	0.00113	0.005	CbGeAlD
Ondansetron—CYP2E1—medulla oblongata—malignant glioma	0.00112	0.00496	CbGeAlD
Ondansetron—Paraesthesia—Temozolomide—malignant glioma	0.00111	0.00498	CcSEcCtD
Ondansetron—Gastrointestinal disorder—Carmustine—malignant glioma	0.0011	0.00495	CcSEcCtD
Ondansetron—Dyspnoea—Temozolomide—malignant glioma	0.0011	0.00494	CcSEcCtD
Ondansetron—Somnolence—Temozolomide—malignant glioma	0.0011	0.00493	CcSEcCtD
Ondansetron—Constipation—Carmustine—malignant glioma	0.00109	0.00491	CcSEcCtD
Ondansetron—Pain—Carmustine—malignant glioma	0.00109	0.00491	CcSEcCtD
Ondansetron—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00107	0.00479	CcSEcCtD
Ondansetron—Fatigue—Temozolomide—malignant glioma	0.00107	0.00478	CcSEcCtD
Ondansetron—Constipation—Temozolomide—malignant glioma	0.00106	0.00474	CcSEcCtD
Ondansetron—Pain—Temozolomide—malignant glioma	0.00106	0.00474	CcSEcCtD
Ondansetron—Feeling abnormal—Carmustine—malignant glioma	0.00105	0.00473	CcSEcCtD
Ondansetron—KCNH2—central nervous system—malignant glioma	0.00105	0.00466	CbGeAlD
Ondansetron—Gastrointestinal pain—Carmustine—malignant glioma	0.00105	0.00469	CcSEcCtD
Ondansetron—KCNH2—cerebellum—malignant glioma	0.00103	0.00455	CbGeAlD
Ondansetron—Feeling abnormal—Temozolomide—malignant glioma	0.00102	0.00457	CcSEcCtD
Ondansetron—Body temperature increased—Carmustine—malignant glioma	0.00101	0.00454	CcSEcCtD
Ondansetron—Abdominal pain—Carmustine—malignant glioma	0.00101	0.00454	CcSEcCtD
Ondansetron—Gastrointestinal pain—Temozolomide—malignant glioma	0.00101	0.00453	CcSEcCtD
Ondansetron—CYP2E1—spinal cord—malignant glioma	0.000999	0.00442	CbGeAlD
Ondansetron—Urticaria—Temozolomide—malignant glioma	0.000981	0.0044	CcSEcCtD
Ondansetron—Abdominal pain—Temozolomide—malignant glioma	0.000977	0.00438	CcSEcCtD
Ondansetron—Body temperature increased—Temozolomide—malignant glioma	0.000977	0.00438	CcSEcCtD
Ondansetron—Hypersensitivity—Carmustine—malignant glioma	0.000942	0.00423	CcSEcCtD
Ondansetron—HTR1A—brain—malignant glioma	0.000938	0.00415	CbGeAlD
Ondansetron—Asthenia—Carmustine—malignant glioma	0.000917	0.00412	CcSEcCtD
Ondansetron—Hypersensitivity—Temozolomide—malignant glioma	0.00091	0.00408	CcSEcCtD
Ondansetron—Asthenia—Temozolomide—malignant glioma	0.000886	0.00398	CcSEcCtD
Ondansetron—Diarrhoea—Carmustine—malignant glioma	0.000875	0.00393	CcSEcCtD
Ondansetron—Pruritus—Temozolomide—malignant glioma	0.000874	0.00392	CcSEcCtD
Ondansetron—Dizziness—Carmustine—malignant glioma	0.000845	0.00379	CcSEcCtD
Ondansetron—Diarrhoea—Temozolomide—malignant glioma	0.000845	0.00379	CcSEcCtD
Ondansetron—KCNH2—brain—malignant glioma	0.000835	0.0037	CbGeAlD
Ondansetron—Dizziness—Temozolomide—malignant glioma	0.000817	0.00367	CcSEcCtD
Ondansetron—Vomiting—Carmustine—malignant glioma	0.000813	0.00365	CcSEcCtD
Ondansetron—CYP2E1—central nervous system—malignant glioma	0.00081	0.00359	CbGeAlD
Ondansetron—Rash—Carmustine—malignant glioma	0.000806	0.00362	CcSEcCtD
Ondansetron—Dermatitis—Carmustine—malignant glioma	0.000805	0.00361	CcSEcCtD
Ondansetron—Headache—Carmustine—malignant glioma	0.000801	0.00359	CcSEcCtD
Ondansetron—CYP2E1—cerebellum—malignant glioma	0.000792	0.0035	CbGeAlD
Ondansetron—Vomiting—Temozolomide—malignant glioma	0.000786	0.00353	CcSEcCtD
Ondansetron—Rash—Temozolomide—malignant glioma	0.000779	0.0035	CcSEcCtD
Ondansetron—Dermatitis—Temozolomide—malignant glioma	0.000778	0.00349	CcSEcCtD
Ondansetron—Headache—Temozolomide—malignant glioma	0.000774	0.00347	CcSEcCtD
Ondansetron—CYP3A4—central nervous system—malignant glioma	0.000652	0.00289	CbGeAlD
Ondansetron—CYP2E1—brain—malignant glioma	0.000643	0.00285	CbGeAlD
Ondansetron—CYP2D6—central nervous system—malignant glioma	0.000642	0.00284	CbGeAlD
Ondansetron—CYP2D6—cerebellum—malignant glioma	0.000627	0.00278	CbGeAlD
Ondansetron—CYP2D6—brain—malignant glioma	0.000509	0.00225	CbGeAlD
Ondansetron—HTR1A—Signaling Pathways—PTK2—malignant glioma	2.66e-05	0.000139	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—TERT—malignant glioma	2.65e-05	0.000139	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—CXCL8—malignant glioma	2.64e-05	0.000139	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—F2—malignant glioma	2.64e-05	0.000139	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—FN1—malignant glioma	2.64e-05	0.000139	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	2.63e-05	0.000138	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—CYP2C18—malignant glioma	2.61e-05	0.000137	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—BAD—malignant glioma	2.61e-05	0.000137	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—HES1—malignant glioma	2.61e-05	0.000137	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—NCOR1—malignant glioma	2.59e-05	0.000136	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—NOTCH1—malignant glioma	2.59e-05	0.000136	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—PDGFB—malignant glioma	2.59e-05	0.000136	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—FGFR1—malignant glioma	2.57e-05	0.000135	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—RAF1—malignant glioma	2.56e-05	0.000134	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.54e-05	0.000133	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—CD80—malignant glioma	2.53e-05	0.000133	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—HIF1A—malignant glioma	2.53e-05	0.000133	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—PIK3CG—malignant glioma	2.53e-05	0.000133	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—APC—malignant glioma	2.53e-05	0.000133	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—IL2—malignant glioma	2.53e-05	0.000133	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—CAV1—malignant glioma	2.52e-05	0.000132	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—EGF—malignant glioma	2.5e-05	0.000131	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—PIK3CB—malignant glioma	2.5e-05	0.000131	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—GSTT1—malignant glioma	2.49e-05	0.000131	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—PDGFRA—malignant glioma	2.48e-05	0.00013	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—PTPN11—malignant glioma	2.48e-05	0.00013	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—IDH2—malignant glioma	2.47e-05	0.00013	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—GSTT1—malignant glioma	2.47e-05	0.00013	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	2.46e-05	0.000129	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—CAV1—malignant glioma	2.45e-05	0.000129	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—GSTP1—malignant glioma	2.44e-05	0.000128	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—GSTP1—malignant glioma	2.43e-05	0.000128	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—KDR—malignant glioma	2.42e-05	0.000127	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—SPP1—malignant glioma	2.41e-05	0.000127	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—CXCL8—malignant glioma	2.4e-05	0.000126	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—BRAF—malignant glioma	2.38e-05	0.000125	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—CAT—malignant glioma	2.37e-05	0.000124	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—CAT—malignant glioma	2.37e-05	0.000124	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—PTGS1—malignant glioma	2.34e-05	0.000123	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—F2—malignant glioma	2.33e-05	0.000122	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—FN1—malignant glioma	2.33e-05	0.000122	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—CYP2B6—malignant glioma	2.33e-05	0.000122	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—PTGS1—malignant glioma	2.32e-05	0.000122	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—AKT2—malignant glioma	2.31e-05	0.000121	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—AKT1—malignant glioma	2.31e-05	0.000121	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.31e-05	0.000121	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—BAD—malignant glioma	2.3e-05	0.000121	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—EGFR—malignant glioma	2.3e-05	0.000121	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—PIK3CG—malignant glioma	2.3e-05	0.00012	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—IL2—malignant glioma	2.29e-05	0.00012	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—TERT—malignant glioma	2.29e-05	0.00012	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—NOTCH1—malignant glioma	2.28e-05	0.00012	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	2.24e-05	0.000118	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—NCOR1—malignant glioma	2.24e-05	0.000118	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—CD80—malignant glioma	2.24e-05	0.000117	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—NCOR1—malignant glioma	2.23e-05	0.000117	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—PIK3CG—malignant glioma	2.23e-05	0.000117	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—APC—malignant glioma	2.23e-05	0.000117	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—PDGFB—malignant glioma	2.23e-05	0.000117	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—PIK3CD—malignant glioma	2.22e-05	0.000117	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—FGFR1—malignant glioma	2.22e-05	0.000117	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—PPARG—malignant glioma	2.22e-05	0.000116	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—EGF—malignant glioma	2.21e-05	0.000116	CbGpPWpGaD
Ondansetron—HTR1B—GPCR downstream signaling—PIK3CA—malignant glioma	2.2e-05	0.000116	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—PTPN11—malignant glioma	2.19e-05	0.000115	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—HIF1A—malignant glioma	2.19e-05	0.000115	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—KRAS—malignant glioma	2.18e-05	0.000114	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—BCHE—malignant glioma	2.17e-05	0.000114	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.17e-05	0.000114	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—BCHE—malignant glioma	2.15e-05	0.000113	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—SLC5A5—malignant glioma	2.15e-05	0.000113	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—FGF2—malignant glioma	2.13e-05	0.000112	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—SLC5A5—malignant glioma	2.13e-05	0.000112	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—IDH1—malignant glioma	2.13e-05	0.000112	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—CAV1—malignant glioma	2.11e-05	0.000111	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—GSTT1—malignant glioma	2.11e-05	0.000111	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—BRAF—malignant glioma	2.1e-05	0.00011	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—KDR—malignant glioma	2.09e-05	0.00011	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—SPHK1—malignant glioma	2.06e-05	0.000108	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—AKT2—malignant glioma	2.04e-05	0.000107	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—EGFR—malignant glioma	2.03e-05	0.000107	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—PIK3CD—malignant glioma	2.02e-05	0.000106	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—CYP2C18—malignant glioma	2.02e-05	0.000106	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—F2—malignant glioma	2.01e-05	0.000106	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—FN1—malignant glioma	2.01e-05	0.000106	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.01e-05	0.000106	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—PIK3CA—malignant glioma	2e-05	0.000105	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.99e-05	0.000105	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—MDM2—malignant glioma	1.99e-05	0.000105	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—BAD—malignant glioma	1.99e-05	0.000104	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—RAF1—malignant glioma	1.98e-05	0.000104	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—PTGS1—malignant glioma	1.98e-05	0.000104	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.97e-05	0.000104	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—NOTCH1—malignant glioma	1.97e-05	0.000103	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—ERBB2—malignant glioma	1.96e-05	0.000103	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—PIK3CD—malignant glioma	1.96e-05	0.000103	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—PIK3CA—malignant glioma	1.94e-05	0.000102	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—PIK3CB—malignant glioma	1.94e-05	0.000102	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—CD80—malignant glioma	1.93e-05	0.000101	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—APC—malignant glioma	1.93e-05	0.000101	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—PIK3CG—malignant glioma	1.93e-05	0.000101	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—KRAS—malignant glioma	1.92e-05	0.000101	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—EGF—malignant glioma	1.9e-05	9.99e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—PTPN11—malignant glioma	1.89e-05	9.93e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—FGF2—malignant glioma	1.88e-05	9.86e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—CXCL8—malignant glioma	1.86e-05	9.77e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—BCHE—malignant glioma	1.84e-05	9.66e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—CAV1—malignant glioma	1.83e-05	9.58e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—CAV1—malignant glioma	1.82e-05	9.56e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—SLC5A5—malignant glioma	1.82e-05	9.55e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—BRAF—malignant glioma	1.81e-05	9.5e-05	CbGpPWpGaD
Ondansetron—HTR1B—GPCR downstream signaling—AKT1—malignant glioma	1.8e-05	9.44e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—CASP3—malignant glioma	1.78e-05	9.35e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—IL2—malignant glioma	1.78e-05	9.34e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—PIK3CA—malignant glioma	1.76e-05	9.26e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—AKT2—malignant glioma	1.76e-05	9.25e-05	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—PIK3CB—malignant glioma	1.76e-05	9.23e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—MDM2—malignant glioma	1.76e-05	9.23e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—EGFR—malignant glioma	1.76e-05	9.21e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—RAF1—malignant glioma	1.75e-05	9.19e-05	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—PTGS2—malignant glioma	1.74e-05	9.15e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.74e-05	9.13e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—ERBB2—malignant glioma	1.73e-05	9.1e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—GSTP1—malignant glioma	1.73e-05	9.08e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.72e-05	9.03e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—GSTP1—malignant glioma	1.71e-05	9e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—PIK3CB—malignant glioma	1.71e-05	8.98e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.7e-05	8.94e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—PIK3CD—malignant glioma	1.69e-05	8.89e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—MMP9—malignant glioma	1.68e-05	8.84e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—CAT—malignant glioma	1.68e-05	8.83e-05	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—PIK3CA—malignant glioma	1.68e-05	8.8e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—PTEN—malignant glioma	1.67e-05	8.79e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—CAT—malignant glioma	1.67e-05	8.76e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—PIK3CG—malignant glioma	1.66e-05	8.73e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—PIK3CG—malignant glioma	1.66e-05	8.71e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—KRAS—malignant glioma	1.66e-05	8.7e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—CXCL8—malignant glioma	1.64e-05	8.63e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—AKT1—malignant glioma	1.63e-05	8.57e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—GSTT1—malignant glioma	1.63e-05	8.56e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—FGF2—malignant glioma	1.62e-05	8.51e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—PPARG—malignant glioma	1.6e-05	8.42e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—PPARG—malignant glioma	1.6e-05	8.41e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—NCOR1—malignant glioma	1.59e-05	8.34e-05	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—AKT1—malignant glioma	1.59e-05	8.33e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—NCOR1—malignant glioma	1.58e-05	8.27e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—CASP3—malignant glioma	1.57e-05	8.26e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—IL2—malignant glioma	1.57e-05	8.24e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—PTGS1—malignant glioma	1.53e-05	8.02e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—PIK3CA—malignant glioma	1.52e-05	8e-05	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—PTEN—malignant glioma	1.52e-05	7.98e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—MDM2—malignant glioma	1.52e-05	7.96e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—VEGFA—malignant glioma	1.51e-05	7.94e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—RAF1—malignant glioma	1.51e-05	7.94e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—STAT3—malignant glioma	1.5e-05	7.86e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—ERBB2—malignant glioma	1.5e-05	7.85e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—MMP9—malignant glioma	1.49e-05	7.8e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.49e-05	7.8e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—PTEN—malignant glioma	1.48e-05	7.76e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—PIK3CB—malignant glioma	1.48e-05	7.75e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—GSTP1—malignant glioma	1.46e-05	7.69e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—PIK3CD—malignant glioma	1.46e-05	7.67e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—PIK3CD—malignant glioma	1.46e-05	7.66e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—AKT1—malignant glioma	1.44e-05	7.57e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—CAT—malignant glioma	1.43e-05	7.48e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—BCHE—malignant glioma	1.42e-05	7.46e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—CXCL8—malignant glioma	1.42e-05	7.45e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—SLC5A5—malignant glioma	1.4e-05	7.37e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—MYC—malignant glioma	1.39e-05	7.3e-05	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—AKT1—malignant glioma	1.37e-05	7.19e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—EGFR—malignant glioma	1.36e-05	7.14e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—CASP3—malignant glioma	1.36e-05	7.13e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—IL2—malignant glioma	1.36e-05	7.12e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—NCOR1—malignant glioma	1.35e-05	7.07e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—VEGFA—malignant glioma	1.33e-05	7.01e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—STAT3—malignant glioma	1.32e-05	6.94e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—CAV1—malignant glioma	1.3e-05	6.8e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—KRAS—malignant glioma	1.29e-05	6.75e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—CAV1—malignant glioma	1.28e-05	6.74e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—MMP9—malignant glioma	1.28e-05	6.73e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—PTEN—malignant glioma	1.28e-05	6.69e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—PIK3CB—malignant glioma	1.27e-05	6.69e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—PIK3CB—malignant glioma	1.27e-05	6.67e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—PTGS2—malignant glioma	1.26e-05	6.63e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—PTGS2—malignant glioma	1.26e-05	6.61e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—AKT1—malignant glioma	1.24e-05	6.53e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—MYC—malignant glioma	1.23e-05	6.45e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.23e-05	6.44e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—EGFR—malignant glioma	1.2e-05	6.3e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—PIK3CA—malignant glioma	1.18e-05	6.2e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—PIK3CG—malignant glioma	1.18e-05	6.19e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—PIK3CG—malignant glioma	1.17e-05	6.14e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—VEGFA—malignant glioma	1.15e-05	6.05e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—TP53—malignant glioma	1.14e-05	6e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—STAT3—malignant glioma	1.14e-05	5.99e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—PPARG—malignant glioma	1.14e-05	5.98e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—KRAS—malignant glioma	1.13e-05	5.96e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—GSTP1—malignant glioma	1.13e-05	5.93e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—PPARG—malignant glioma	1.13e-05	5.93e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—PTEN—malignant glioma	1.1e-05	5.78e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—CAT—malignant glioma	1.1e-05	5.77e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—PTEN—malignant glioma	1.1e-05	5.77e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—CAV1—malignant glioma	1.1e-05	5.76e-05	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—PIK3CA—malignant glioma	1.07e-05	5.63e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—MYC—malignant glioma	1.06e-05	5.56e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.05e-05	5.5e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—PIK3CA—malignant glioma	1.04e-05	5.47e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—NCOR1—malignant glioma	1.04e-05	5.45e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—PIK3CD—malignant glioma	1.04e-05	5.44e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—EGFR—malignant glioma	1.04e-05	5.44e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—PIK3CD—malignant glioma	1.03e-05	5.4e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—TP53—malignant glioma	1.01e-05	5.29e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—PIK3CG—malignant glioma	1e-05	5.25e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—KRAS—malignant glioma	9.79e-06	5.14e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—AKT1—malignant glioma	9.65e-06	5.06e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—PPARG—malignant glioma	9.65e-06	5.06e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—PIK3CB—malignant glioma	9.04e-06	4.75e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—PIK3CA—malignant glioma	9e-06	4.72e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—PIK3CB—malignant glioma	8.96e-06	4.7e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—PTGS2—malignant glioma	8.96e-06	4.7e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—PTGS2—malignant glioma	8.88e-06	4.66e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—PIK3CD—malignant glioma	8.79e-06	4.61e-05	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—AKT1—malignant glioma	8.76e-06	4.6e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—TP53—malignant glioma	8.71e-06	4.57e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—AKT1—malignant glioma	8.52e-06	4.47e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—CAV1—malignant glioma	8.47e-06	4.45e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—PTEN—malignant glioma	7.81e-06	4.1e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—PIK3CA—malignant glioma	7.77e-06	4.08e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—PIK3CA—malignant glioma	7.75e-06	4.07e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—PTEN—malignant glioma	7.75e-06	4.07e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—PIK3CG—malignant glioma	7.71e-06	4.05e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—PIK3CB—malignant glioma	7.66e-06	4.02e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—PTGS2—malignant glioma	7.59e-06	3.98e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—PPARG—malignant glioma	7.45e-06	3.91e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—AKT1—malignant glioma	7.35e-06	3.86e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—PIK3CD—malignant glioma	6.78e-06	3.56e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—PTEN—malignant glioma	6.62e-06	3.47e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—AKT1—malignant glioma	6.35e-06	3.33e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—AKT1—malignant glioma	6.33e-06	3.32e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—PIK3CB—malignant glioma	5.91e-06	3.1e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—PTGS2—malignant glioma	5.86e-06	3.07e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—PIK3CA—malignant glioma	5.51e-06	2.89e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—PIK3CA—malignant glioma	5.46e-06	2.87e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—PTEN—malignant glioma	5.11e-06	2.68e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—PIK3CA—malignant glioma	4.67e-06	2.45e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—AKT1—malignant glioma	4.5e-06	2.36e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—AKT1—malignant glioma	4.46e-06	2.34e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—AKT1—malignant glioma	3.81e-06	2e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—PIK3CA—malignant glioma	3.6e-06	1.89e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—AKT1—malignant glioma	2.94e-06	1.55e-05	CbGpPWpGaD
